The Desmoid Tumor Research Foundation

October 2020

Desmoid tumors: To treat or not to treat, that is the question

Author Information

Kasper B(1), Raut CP(2), Gronchi A(3).

(1)Sarcoma Unit, Mannheim Univ Medical Center, Univ of Heidelberg, Mannheim, Germany. (2)Division of Surgical Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. (3)Sarcoma Service, Dept of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Publication

Cancer

Summary

More than 5 years ago, The Desmoid Tumor Working Group started a consensus initiative in Europe with the aim of harmonizing the strategy among clinicians and setting up treatment recommendations for patients with desmoid tumors (DTs). This review summarizes the latest joint, global, evidence-based guideline approach to DT management. Moreover, a number of gray areas in the treatment recommendations are discussed, and possible future perspectives on the treatment armamentarium for patients with DTs are presented.

View Abstract